As the major health industry base under the Chinese National Pharmaceutical Group, Sinopharm Xingsha Pharmaceuticals is a state-owned enterprise with a history of seventy years. Morishita Jintan corporation is a 100-year-old publicly traded company with multiple research centers and manufacturing bases throughout Japan.

In 2020, Sinopharm Xingsha achieved a strong partnership with Morishita Jintan and became its general agent in China, responsible for the marketing of Bifina probiotic which gained triple certification from GMP, FDA, and HACCP. (Source: ixingyingyang)

Comments are closed.